№ files_lp_4_process_3_104320
File format: docx
Character count: 1757
File size: 16 KB
Step-by-step guidance for students on submitting original essays for the Patriot’s Pen scholarship through electronic or physical channels, including formatting and eligibility rules.
Year:
2026
Region / City:
United States
Theme:
Patriotism
Document Type:
Scholarship submission instructions
Organization:
Veterans of Foreign Wars (VFW)
Audience:
Students eligible for Patriot’s Pen competition
Submission Platform:
Scholar’s App Scholarship Platform
Essay Requirements:
300–400 words, typed, original work, no personal identification
Submission Methods:
Electronic via Scholar’s App, email, or hard copy to local Post
Evaluation Criteria:
Essay content only, no oral presentation required
Restrictions:
One entry per student per year, poetry not accepted, quotations allowed if cited
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2024
Region / City:
Olentangy Patriots
Theme:
Little League Regulations
Document Type:
Policies and Rules
Organization / Institution:
Olentangy Patriots Little League
Author:
Olentangy Patriots Little League
Target Audience:
Coaches, Managers, and Umpires
Period of Validity:
2024 season
Approval Date:
Not specified
Date of Changes:
Not specified
Year:
2026
Region / City:
Area 10 E
Theme:
Sports / Soccer Tournament
Document Type:
Tournament Rules
Organization / Institution:
AYSO (American Youth Soccer Organization)
Author:
AYSO Tournament Committee
Target Audience:
Coaches, Teams, Referees, Participants
Period of Validity:
May 2026
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2022
Region:
Not specified
Topic:
Youth referee authorization
Document type:
Authorization letter
Organization/Institution:
AYSO (American Youth Soccer Organization)
Author:
Not specified
Target audience:
Youth referees, Tournament officials
Period of validity:
Not specified
Approval date:
11/6/2022
Modification date:
Not specified
Year:
1787–1789
Location:
United States
Topic:
Constitutional History
Document Type:
Educational Analysis / Primary Source Compilation
Institution:
United States Congress / Historical Archives
Author:
Multiple historical figures and compilers
Intended Audience:
Students, researchers, and history enthusiasts
Key Figures Mentioned:
Patrick Henry, George Mason, George Washington, Benjamin Franklin, James Madison, Thomas Jefferson
Event Date:
September 17, 1787
Creation Date of Artwork:
1939
Artist:
Howard Chandler Christy
Purpose:
Examine early objections and debates surrounding the U.S. Constitution
Included Documents:
Speeches, letters, and objections from the Constitutional Convention and Ratification Conventions
Contextual Focus:
Understanding reasons behind initial opposition to the Constitution by prominent patriots
Year:
2026
Region / City:
United States
Theme:
American Football, Super Bowl, Patriots
Document Type:
Press Conference Transcript
Organization / Institution:
New England Patriots
Author:
Drake Maye
Target Audience:
Sports Fans, Patriots Supporters
Period of Action:
February 2026
Approval Date:
February 5, 2026
Date of Changes:
N/A
Year:
2026
Region / City:
New England
Topic:
American Football, NFL
Document Type:
Press Conference Transcript
Organization:
New England Patriots
Author:
Drake Maye
Target Audience:
Sports fans, football enthusiasts, NFL followers
Period of Validity:
February 2026
Approval Date:
February 10, 2026
Date of Changes:
N/A
Year:
2023
Region / City:
Australia
Subject:
Chronic migraine, medicinal product submission
Document type:
Submission for PBS listing
Organization:
Novartis Pharmaceuticals Australia Pty. Limited
Author:
Not specified
Target audience:
Health professionals, pharmaceutical regulatory bodies
Period of validity:
Not specified
Date of approval:
2 July 2018
Date of amendments:
November 2023
Year:
2020
Region / City:
Australia
Topic:
Pharmaceutical Benefits Scheme (PBS) listing
Document Type:
Committee Submission
Agency:
PBAC (Pharmaceutical Benefits Advisory Committee)
Author:
Committee Secretariat
Target Audience:
Healthcare professionals, PBAC members
Period of Effect:
From May 13, 2020
Approval Date:
May 13, 2020
Modification Date:
Not specified
Year:
2005
Region / City:
Not specified
Topic:
Digital Pen Technology
Document Type:
User Manual
Organization / Institution:
DSS
Author:
Not specified
Target Audience:
Users of IntelliPen
Period of Validity:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2021
Region / City:
Australia
Topic:
Pharmaceutical Submission
Document Type:
Regulatory Submission
Agency / Institution:
PBAC
Author:
CELLTRION HEALTHCARE AUSTRALIA PTY LTD
Target Audience:
Healthcare professionals, regulatory authorities
Effective Period:
2021 and ongoing
Approval Date:
25 August 2021
Date of Changes:
March 2022
Year:
2022
Region / City:
Australia
Subject:
Pharmacology, Pharmaceutical Benefits Scheme (PBS)
Document Type:
Submission
Organization / Institution:
Sanofi-Aventis Australia Pty Ltd
Author:
Not specified
Target Audience:
Medical practitioners, healthcare professionals
Period of validity:
Not specified
Approval Date:
3 June 2022
Date of Changes:
Not specified
Contextual Description:
A regulatory submission detailing the request for listing of dupilumab in new forms for treating severe atopic dermatitis and uncontrolled severe asthma in pediatric patients under the PBS.
Year:
2015
Region / city:
Australia
Theme:
Hypercholesterolemia treatment
Document type:
Pharmaceutical submission
Organization / institution:
Amgen Australia Pty Limited
Author:
Amgen Australia Pty Limited
Target audience:
Healthcare professionals
Period of validity:
Ongoing
Approval date:
4 December 2015
Date of amendments:
December 2022
Context:
Submission to modify existing PBS listings for evolocumab for the treatment of different types of hypercholesterolemia, including changes to prescription requirements and treatment duration.
Year:
2022
Region / city:
Australia
Theme:
Rheumatoid Arthritis, Pharmaceutical submission
Document type:
Submission for PBS listing
Organization / institution:
Celltrion Healthcare Australia Pty Ltd
Author:
Celltrion Healthcare Australia Pty Ltd
Target audience:
Health professionals, regulators
Period of validity:
Not specified
Approval date:
Not specified
Date of changes:
Not specified
Note:
Year
Contextual description:
The document is a guide to configuring ERP processes for sales and distribution modules in SAP S/4HANA using the Pen Company example, with step-by-step exercises.
Note:
Year
Contextual description:
A guide detailing SAP S/4HANA system configuration for Financial Accounting and Materials Management modules, focusing on organizational structures, company code creation, and credit control setup.
Year:
2022
Region / City:
Australia
Theme:
Chronic rhinosinusitis with nasal polyps, Pharmacology
Document Type:
Application for PBS listing
Authority / Institution:
PBAC, TGA
Author:
GlaxoSmithKline Australia Pty Ltd
Target Audience:
Healthcare professionals, medical practitioners
Validity Period:
Not specified
Approval Date:
Not specified
Modification Date:
Not specified
Year:
2020
Region / City:
Australia
Theme:
Pharmaceutical submission, medical treatment
Document Type:
Submission
Organization / Institution:
Takeda Pharmaceuticals Australia Pty Ltd
Author:
Takeda Pharmaceuticals Australia Pty Ltd
Target Audience:
Medical practitioners, gastroenterologists
Period of Validity:
Not specified
Approval Date:
12 May 2020
Modification Date:
Not specified
Registration Status:
Registered by TGA
Clinical Claim:
VDZ SC is as effective as VDZ IV for maintenance treatment in MSUC and severe CD
Indications:
Treatment for moderate to severe ulcerative colitis and Crohn’s disease
Requested Listings:
PBS listing for VDZ SC as maintenance treatment
Prescriber Instructions:
Specific guidelines for initiating subcutaneous therapy
Administrative Advice:
Applications for authorisation under PBS can be made online or by phone
Contextual Description:
A pharmaceutical submission for the approval of vedolizumab (VDZ SC) as a maintenance treatment for moderate to severe ulcerative colitis and severe Crohn’s disease based on a cost-minimisation analysis.
Year:
2017
Region / City:
Australia
Theme:
Pharmaceutical application
Document type:
Resubmission for Authority Required listing
Organ / Institution:
PBAC
Author:
Janssen-Cilag Pty Ltd
Target audience:
Medical professionals, regulatory bodies
Validity period:
Ongoing
Approval date:
November 2017
Modification date:
Not specified
Note:
Year